REGENERON PHARMACEUTICALS, INC. Diversified Active

CIK: 0000872589 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 1, 2025

Total Value ($000): $1,485,003 (100.0% shares, 0.0% debt)

Holdings (4)

ALNY Alnylam Pharmaceuticals, Inc. 97.6%

Value ($000) $1,449,289 Shares 4,444,445 Est. Cost $262.99 Unrealized +5.2%

NTLA Intellia Therapeutics, Inc. 2.3%

Value ($000) $34,734 Shares 3,702,995 Est. Cost $15.61 Unrealized -47.4%

— Adicet Bio, Inc. 0.0%

Value ($000) $591 Shares 968,183 Est. Cost $0.96 Unrealized —

— Adverum Biotechnologies, Inc. 0.0%

Value ($000) $389 Shares 180,909 Est. Cost $4.67 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ALNY	Alnylam Pharmaceuticals, Inc.	4,444,445	$1,449,289	97.6%	$262.99	+5.2%	Common Stock	02043Q107
NTLA	Intellia Therapeutics, Inc.	3,702,995	$34,734	2.3%	$15.61	-47.4%	Common Stock	45826J105
—	Adicet Bio, Inc.	968,183	$591	0.0%	$0.96	—	Common Stock	007002108
—	Adverum Biotechnologies, Inc.	180,909	$389	0.0%	$4.67	—	Common Stock	00773U207